Cranberry for Cardiovascular Disease

Verdict: Weak, surrogate-only evidence; no proven heart benefit

Cranberry is not a proven treatment for cardiovascular disease. The largest meta-analysis found no effect on blood pressure, and the only positive signals come from small trials measuring surrogate markers rather than real heart outcomes.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade is held low because the strongest evidence is null. The largest and most recent meta-analysis (PMID 37963472, 17 RCTs) found no significant change in blood pressure (systolic -0.81 mmHg, diastolic -0.15 mmHg), with only 2 of 17 trials positive. An earlier meta-analysis (PMID 31023488) saw at most a modest systolic dip, no lipid improvement, and noted that juice formulations may even raise triglycerides.

The positive findings come almost entirely from small, short trials of surrogate markers. Cranberry improved flow-mediated dilation in healthy adults (PMID 35322843, n=45) and acutely in a 10-person dose-response study (PMID 27242317), and one trial in coronary patients lowered arterial stiffness by about 0.5 m/s (PMID 21411615, n=44). An industry-funded trial in people with elevated blood pressure (PMID 34444779, Ocean Spray) missed its primary endpoint. No trial has tested heart attacks, stroke, or mortality.

Regulators and clinicians do not endorse cranberry for the heart. The FDA calls the overall evidence 'limited and inconsistent' and only for urinary-tract infections, EFSA rejected a cardiovascular claim, and the WHO offers only a reference monograph. Mayo Clinic, Harvard, and the AHA/ACC do not address it. The NHS adds a safety caveat that matters here: people on warfarin, common among heart patients, should avoid cranberry products.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.48
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
78%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.55
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.485
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (6)L2 · primary research & systematic reviews

The effects of blueberry and cranberry supplementation on blood pressure in patients with cardiovascular diseases: A systematic review and meta-analysis of randomized clinical trials
PMID: 37963472 2024 統合分析
Finding: Blueberry and/or cranberry supplementation had neutral effects on blood pressure in patients with cardiometabolic disease: SBP -0.81 mmHg (95% CI -2.26 to 0.63, I2=0%) and DBP -0.15 mmHg (95% CI -1.36 to 1.05, I2=27%); only 2 of 17 included studies showed a significant effect.
Government Effect size: MD SBP -0.81 mmHg (NS); DBP -0.15 mmHg (NS)
View on PubMed
The effects of cranberry on cardiovascular metabolic risk factors: A systematic review and meta-analysis
PMID: 31023488 2020 統合分析
Finding: Cranberry produced modest reductions in SBP and BMI, with greater SBP improvement in older adults (≥50 y); no significant change in triglycerides, total cholesterol, LDL, HDL, fasting glucose, insulin resistance, DBP, waist circumference or inflammatory markers; juice formulations were associated with elevated triglycerides.
🟠 Limited quality Effect size: Modest SBP reduction; lipid and DBP outcomes NS
View on PubMed
Daily consumption of cranberry improves endothelial function in healthy adults: a double blind randomized controlled trial
PMID: 35322843 2022 隨機對照試驗 n = 45
Finding: Daily cranberry powder significantly improved FMD acutely (2 h) and after 1 month versus control in healthy men; no significant change in pulse wave velocity, aortic augmentation index, blood pressure, heart rate, blood lipids or glucose.
Effect size: FMD +1.1% (95% CI 1.1 to 1.8, p<=0.001); PWV/BP/lipids NS
View on PubMed
Effects of cranberry juice consumption on vascular function in patients with coronary artery disease
PMID: 21411615 2011 隨機對照試驗 n = 44
Finding: Chronic cranberry juice reduced carotid-femoral pulse wave velocity (8.3 to 7.8 m/s vs placebo 8.0 to 8.4 m/s, p=0.003), a clinically relevant measure of arterial stiffness; no chronic effect on endothelial vasodilator function; acute pilot improved FMD and pulse amplitude tonometry.
Government Effect size: PWV reduction ~0.5 m/s vs placebo (p=0.003); chronic FMD NS
View on PubMed
Effects of Cranberry Juice Supplementation on Cardiovascular Disease Risk Factors in Adults with Elevated Blood Pressure: A Randomized Controlled Trial
PMID: 34444779 2021 隨機對照試驗 n = 40
Finding: Cranberry juice had no significant effect on the primary endpoint of central systolic BP or on central/brachial diastolic BP; it reduced 24-h daytime ambulatory diastolic BP by ~2 mmHg (p=0.05) and modestly increased large LDL particles and LDL size; industry-funded (Ocean Spray).
🟠 Limited quality ⚠️ Industry-funded Effect size: Central SBP NS; daytime ambulatory DBP -2 mmHg (p=0.05)
View on PubMed
Cranberry (poly)phenol metabolites correlate with improvements in vascular function: A double-blind, randomized, controlled, dose-response, crossover study
PMID: 27242317 2016 隨機對照試驗 n = 10
Finding: Acute cranberry juice produced dose-dependent increases in FMD (peak at 4 h, maximal effect at 1238 mg total polyphenols) in 10 healthy males; very small sample with surrogate-marker outcomes only.
🟠 Limited quality Effect size: Dose-dependent acute FMD increase; no chronic data
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
Limited and inconsistent scientific evidence shows that by consuming one serving (8 oz) each day of a cranberry juice beverage, healthy women who have had a urinary tract infection (UTI) may reduce their risk of recurrent UTI. source↗
L4b EU EFSA
Against
L4c UK NHS
Neutral
Some people who are not pregnant take cystitis sachets or cranberry drinks and products to prevent UTIs from happening, which may help. If you're taking warfarin, you should avoid cranberry products. source↗
L4d TW TFDA / 衛福部
Neutral
目前核准的健康食品保健功效包括調節血脂、胃腸功能改善、護肝、免疫調節、骨質保健、不易形成體脂肪、抗疲勞、輔助調整過敏體質、調節血糖、延緩衰老、牙齒保健、促進鐵吸收、輔助調節血壓等共13項。 source↗
L4e WHO
Neutral
WHO monographs on selected medicinal plants, Volume 4, includes a monograph on Fructus Macrocarpi (cranberry, the fruit of Vaccinium macrocarpon Aiton). source↗
L5a NIH Office of Dietary Supplements
Cautious
L5c Cleveland Clinic
Neutral
L5e Specialty Society (condition-mapped)
Not addressed
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬6 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-cardiovascular-disease-INT-cranberry-001 繁體中文版 →